These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 16209022
21. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Isakova ZhT. Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033 [Abstract] [Full Text] [Related]
22. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis]. Skotnikova OI, Mikhaĭlovich VM, Nosova EIu, Lapa SA, Griadunov DA, Donnikov MIu, Badleeva MV, Galkina KIu, Dorozhkova IR, Litvinov VI, Zasedatelev AS, Moroz AM, Mirzabekov AD. Probl Tuberk Bolezn Legk; 2004 May; (6):40-2. PubMed ID: 15315132 [Abstract] [Full Text] [Related]
23. Detection of multidrug resistance in Mycobacterium tuberculosis. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T. J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078 [Abstract] [Full Text] [Related]
24. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Lithuania. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P. Int J Tuberc Lung Dis; 2005 Aug; 9(8):936-8. PubMed ID: 16104644 [Abstract] [Full Text] [Related]
25. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. Evans J, Stead MC, Nicol MP, Segal H. J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875 [Abstract] [Full Text] [Related]
26. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Zhao JR, Bai YJ, Zhang QH, Wang Y, Luo M, Yan XJ. Diagn Microbiol Infect Dis; 2005 Feb; 51(2):135-7. PubMed ID: 15698720 [Abstract] [Full Text] [Related]
27. Standardisation and evaluation of DNA-lanthanide fluorescence spectroscopy for determining rifampicin resistance in Mycobacterium tuberculosis clinical isolates. Mani C, Selvakumar N, Gajendiran N, Panigrahi B, Venkatesan P, Narayanan PR. Int J Tuberc Lung Dis; 2003 Sep; 7(9):873-8. PubMed ID: 12971672 [Abstract] [Full Text] [Related]
28. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. Science; 2006 Jun 30; 312(5782):1944-6. PubMed ID: 16809538 [Abstract] [Full Text] [Related]
29. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S. Int J Tuberc Lung Dis; 2005 Oct 30; 9(10):1161-7. PubMed ID: 16229229 [Abstract] [Full Text] [Related]
30. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients. Zaker Bostanabad S, Titov LP, Slizen VV, Taghikhani M, Bahrmand A. Tuberk Toraks; 2007 Oct 30; 55(3):231-7. PubMed ID: 17978919 [Abstract] [Full Text] [Related]
31. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone]. Belianin II, Shmelev EI. Probl Tuberk Bolezn Legk; 2004 Oct 30; (7):32-5. PubMed ID: 15379039 [Abstract] [Full Text] [Related]
32. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. J Infect; 2005 Oct 30; 51(3):175-87. PubMed ID: 16002146 [Abstract] [Full Text] [Related]
33. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. Shenai S, Rodrigues C, Mehta A. Int J Infect Dis; 2009 Jan 30; 13(1):46-58. PubMed ID: 18565777 [Abstract] [Full Text] [Related]
34. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. Kurabachew M, Lu SH, Krastel P, Schmitt EK, Suresh BL, Goh A, Knox JE, Ma NL, Jiricek J, Beer D, Cynamon M, Petersen F, Dartois V, Keller T, Dick T, Sambandamurthy VK. J Antimicrob Chemother; 2008 Oct 30; 62(4):713-9. PubMed ID: 18587134 [Abstract] [Full Text] [Related]
35. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. Soudani A, Hadjfredj S, Zribi M, Masmoudi A, Messaoud T, Tiouri H, Fendri C. J Clin Microbiol; 2007 Sep 30; 45(9):3095-7. PubMed ID: 17652484 [Abstract] [Full Text] [Related]
37. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM. Probl Tuberk Bolezn Legk; 2004 Sep 30; (3):32-7. PubMed ID: 15338898 [Abstract] [Full Text] [Related]
38. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Kuz'min AV, Vasil'eva IA, Chernousova LN. Probl Tuberk Bolezn Legk; 2006 Sep 30; (8):17-23. PubMed ID: 17002052 [Abstract] [Full Text] [Related]
39. [Susceptibility test to rifampin by using quantitative analysis of Mycobacterium tuberculosis mRNA]. Lu Y, Zhu LZ, Chu NH, Duan LS, Liang GF. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug 30; 27(8):549-52. PubMed ID: 15388006 [Abstract] [Full Text] [Related]
40. [Bactericidal therapy in patients with tuberculosis]. Krasnov VA, Ursov IG. Probl Tuberk Bolezn Legk; 2004 Aug 30; (3):21-6. PubMed ID: 15338895 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]